EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Immunogenic Cuproptosis Evoked by In Situ Sulfidation‐Activated Pyroptosis for Tumor‐Targeted Immunotherapy of Colorectal Cancer

Wentao Xiao, Kuiming Qu, Wei Zhang, Lunhui Lai, Lei He, Fang Cheng iD, Lianhui Wang iD

Small Science · 2024-03 · 4 (3)

DOI: 10.1002/smsc.202300164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Science, online erschienen am 17.01.2024. Verfasst von Wentao Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors Institute of Advanced Materials (IAM) N…. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the great potential of cuproptosis in tumor therapy, the current cuproptosis‐based therapy still suffers from compromised efficiency of immune activation. Pyroptosis, a proinflammatory cell death modality, provides a good opportunity to induce immunogenic cell death (ICD) and promote systemic immune response. However, the synergistic cuproptosis and pyroptosis therapy has not been fully explored. Herein, it is discovered that Cu(II)‐based metal–organic framework (MOF) nanoparticles (NPs) can synergistically induce cuproptosis and pyroptosis to evoke ICD for high‐efficiency tumor‐targeted immunotherapy. Although MOF‐199 has been widely used in tumor therapy, the immunogenicity is still unclear. Pluronic F127‐modified MOF‐199 NPs ( F127 MOF‐199 NPs) show dual‐responsiveness to glutathione (GSH) and hydrogen sulfide (H 2 S). Once entering cancer cells, F127 MOF‐199 NPs dissociate in GSH‐enriched tumor microenvironment (TME) to release copper ion and induce copper‐overload‐mediated cuproptosis. Meanwhile, F127 MOF‐199 NPs transform to Cu 2− x S NPs by in situ sulfidation under H 2 S‐enriched colorectal cancer (CRC) TME. Under photothermal and chemodynamic therapy (PTT/CDT) of Cu 2− x S NPs, caspase‐3 is activated and gasdermin E (GSDME)‐related pyroptosis is triggered. The synergistic cuproptosis and pyroptosis have proved the superior antitumor immunity effect in both in vitro and in vivo experiments. This work provides a new strategy to achieve tumor‐targeted immunotherapy with high efficiency by simple F127 MOF‐199 NPs.

Schlagwörter

Stichwörter der Autor:innen

MOF-199cuproptosisimmunotherapyin situ sulfidationpyroptosis

Autor:innen und Institutionen

  • State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors Institute of Advanced Materials (IAM) Nanjing University of Posts and Telecommunications Nanjing 210023 P. R.…

ORCID-Profile: Fang Cheng, Lianhui Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiao, W., Qu, K., Zhang, W., Lai, L., He, L., Cheng, F., & Wang, L. (2024). High Immunogenic Cuproptosis Evoked by In Situ Sulfidation‐Activated Pyroptosis for Tumor‐Targeted Immunotherapy of Colorectal Cancer. Small Science, 4(3). https://doi.org/10.1002/smsc.202300164

Vancouver

Xiao W, Qu K, Zhang W, Lai L, He L, Cheng F, et al. High Immunogenic Cuproptosis Evoked by In Situ Sulfidation‐Activated Pyroptosis for Tumor‐Targeted Immunotherapy of Colorectal Cancer. Small Science. 2024;4(3). doi:10.1002/smsc.202300164

BibTeX
@article{Xiao2024,
  author = {Xiao, Wentao and Qu, Kuiming and Zhang, Wei and Lai, Lunhui and He, Lei and Cheng, Fang and Wang, Lianhui},
  title = {High Immunogenic Cuproptosis Evoked by In Situ Sulfidation‐Activated Pyroptosis for Tumor‐Targeted Immunotherapy of Colorectal Cancer},
  journal = {Small Science},
  year = {2024},
  volume = {4},
  number = {3},
  doi = {10.1002/smsc.202300164}
}
Kostenlos starten →